Imaging in 2020 III
September 7-11, 2003

Organizers: Thomas Meade, Daniel Sullivan, and James Tatum


Novel Discovery Approaches to Targets, Ligands, and Methods to Monitor Interactions
Charles Cantor, Sequenom

Developing Imaging Agents through High Throughput Screening
Ralph Weissleder, Massachusetts General Hospital

Chair: Bob Gillies, University of Arizona

3D Imaging of Genome Events in Cancer
Joe Gray, UCSF

Image-Based Screening for Drug Discovery: Macro and Micro Applications
Peter Ramm, Amersham Biosciences

PET-Ready Chemistry: An Enabling Strategy for Tracer Development
Derek Maclean

Harnessing the Human Visual System for Multi-Dimensional Biomedical Image Analysis
David Laidlaw, Brown University

Genomic Approaches to Novel Molecular Target Identification and Translation
Jeffrey Trent, Translational Genomics Research Institute

Screening of Agents that Image Hypoxia
Michael Welch, Washington University

Chair: David Piwnica-Worms, Washington University

High Throughput Targeted Drug Treatment Assessments
Ronald Blasberg, Memorial Sloan-Kettering Cancer Center

On the way to MRI Relaxivities over 100: Fast Water Exchange in Hydroxypyridinone-based Gadolinium Complexes
Ken Raymond, UC Berkeley

Application of One-Bead One-Compound Combinatorial Library Methods to Discover Cancer Imaging Agents
Kit Lam, UC Davis

Comparison of the Binding of the Monoamine Oxidase A & B Radiotracers [11C] Clorgyline and [11C] l-Deprenyl in Human Brain and Peripheral Organs
Joanna Fowler, Brookhaven National Labs

Keynote Address

Microtools for Biology
George Whitesides, Harvard University

Chair: Tom Budinger, Lawrence Berkeley National Lab

Imaging in Glioma: State-of-the-art?
Tom Mikkelson, UC Berkeley

Near Infrared Molecular Probes for Imaging Protein Expression
Samuel Achilefu, Washington University

Development of Magnetic Nanoparticle Libraries as Imaging Agents
Lee Josephson, Massachusetts General Hospital

Multidimensional Biomedical Imaging: Fusion of Form and Function
Richard Robb, Mayo Clinic Foundation

Luminescent Quantum Dots for Molecular Imaging
Shuming Nie, Emory University & Georgia Institute of Technology

The Use of PET and Knock Out Mice in the Drug Discovery Process
William Eckelman, National Institutes of Health

Chair: Tom Meade,California Institute of Technology

Peptide Phage Display for Pharmacophore Identification and Lead Generation of Diagnostic Drugs
Adrian Nunn, Bracco Research USA

Approaches to In Vivo Imaging of Pharmacologic Modulation of Hypoxic Cell Signaling
Robert Shoemaker, National Cancer Institute

Monitoring Immune Cell Infiltration and Detecting Graft Rejection following Organ Transplantation by MRI
Chien Ho, Carnegie Mellon University

Comments are closed.